Kahira Pharmaceuticals & Chemical Industries Co. (CPCI) Net Income
Net Income
EGP 85.17M
Fiscal year 2019
Net income is the profit remaining after all operating costs, interest and taxes are deducted from revenue — the bottom line of the income statement. A negative figure means the company recorded a loss for that fiscal year.
Net income history
| Fiscal year | Net income | YoY growth | Net margin |
|---|---|---|---|
| 2019 | 85.17M | -21.47% | 8.84% |
| 2018 | 108.45M | 10.75% | 12.57% |
| 2017 | 97.92M | 90.7% | 14.19% |
| 2016 | 51.35M | 18.42% | 9.94% |
| 2015 | 43.36M | 5.5% | 9.61% |
| 2014 | 41.1M | -23.87% | 10.16% |
| 2013 | 53.98M | 46.08% | 14.4% |
| 2012 | 36.95M | -17.9% | 10.78% |
| 2011 | 45.01M | -7.4% | 14.73% |
| 2010 | 48.61M | -6% | 16.83% |
| 2009 | 51.71M | 1.36% | 19.25% |
| 2008 | 51.01M | 11.27% | 19.62% |
| 2007 | 45.84M | 19.32% | 18.78% |
| 2006 | 38.42M | — | 16.56% |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.